Home > Search Results

Results: 1 to 20 of 21

Treatment of chronic atrophic gastritis with Chinese medicines: a systematic review

Bibliographic details: Huang X, Lv B.  Treatment of chronic atrophic gastritis with Chinese medicines: a systematic review. World Chinese Journal of Digestology 2010; 18(10): 1056-1062

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2010

Acupuncture and moxibustion for treatment of chronic atrophic gastritis: a meta-analysis

Bibliographic details: Liao WL, Chen GZ, Hu H, Xia LM.  Acupuncture and moxibustion for treatment of chronic atrophic gastritis: a meta-analysis. World Chinese Journal of Digestology 2014; 22(2): 233-238

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2014

Weifuchun for chronic atrophic gastritis: a systematic review

Bibliographic details: Zhu LL, Tian JH, Bai ZG, Yang KH, Wu J, Zhao FH, Ma B.  Weifuchun for chronic atrophic gastritis: a systematic review. Chinese Journal of Evidence-Based Medicine 2009; 9(1): 81-87

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2009

Combination of Chinese and Western medicine for treatment of chronic atrophic gastritis: a meta-analysis

Bibliographic details: Kong YJ, Li Y, Li WL, Liu H, Wei MX.  Combination of Chinese and Western medicine for treatment of chronic atrophic gastritis: a meta-analysis. World Chinese Journal of Digestology 2013; 21(20): 1982-1986

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2013

Meta-analysis on the validity of pepsinogen test for gastric carcinoma, clysplasia or chronic atrophic gastritis screening

AIM: To assess the validity of the measurement of pepsinogen I and II as a screening test for gastric cancer and pre-malignant lesions, namely low-grade dysplasia, both in the general population and in selected groups of patients.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2004

Effect of the long‐term use of proton pump inhibitors on the rate of pre‐cancerous lesions in the stomach

PPIs are the most effective drugs used to reduce gastric acid secretion (called antacids) and they are commonly prescribed worldwide. Although generally safe, their effectiveness and safety for long‐term use remains unclear. It has been suggested that the long‐term use of PPIs could promote the development of pre‐cancerous lesions in the stomach, which might subsequently increase the occurrence of stomach cancer. Therefore, the safety issues of long‐term PPI treatment needs to be addressed.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2015

Chaihu-Shugan-San, an oriental herbal preparation, for the treatment of chronic gastritis: a meta-analysis of randomized controlled trials

ETHNOPHARMACOLOGICAL RELEVANCE: Chronic gastritis is a very common disease of the digestive tract. Although herbal preparation Chaihu-Shugan-San (CSS) has been widely used as an alternative treatment for chronic gastritis in East Asia, its effectiveness is not verified. The purpose of this meta-analysis is to evaluate the effectiveness of CSS in treating various types of chronic gastritis.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2013

Psoriasis: Assessment and Management of Psoriasis

Psoriasis is a common, chronic disease, which for many people, is associated with profound functional, psychological and social morbidity and important comorbidities. Effective treatments are available. Some treatments are expensive; all require appropriate monitoring and some may only be accessed in specialist care settings. Evidence indicates that a substantial proportion of people with psoriasis are currently dissatisfied with their treatment.

NICE Clinical Guidelines - National Clinical Guideline Centre (UK).

Version: October 2012

Drug Class Review: Proton Pump Inhibitors: Final Report Update 5 [Internet]

Proton pump inhibitors decrease secretion of gastric acid. They act by blocking the last enzyme in the system that actively transports acid from gastric parietal cells into the gastrointestinal lumen, hydrogen–potassium adenosine triphosphatase, also known as the proton pump. Omeprazole, the first drug in this class, was introduced in 1989. Since then, 4 other proton pump inhibitors have been introduced: lansoprazole (1995), rabeprazole (1999), pantoprazole (2000), and esomeprazole (2001). In 2003 omeprazole became available over-the-counter in the United States. The purpose of this review is to compare the benefits and harms of different PPIs.

Drug Class Reviews - Oregon Health & Science University.

Version: May 2009
Show search results within this document

Stomach (Gastric) Cancer Screening (PDQ®): Health Professional Version

Expert-reviewed information summary about tests used to detect or screen for stomach (gastric) cancer.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: March 10, 2017

Stomach (Gastric) Cancer Prevention (PDQ®): Health Professional Version

Expert-reviewed information summary about factors that may influence the risk of developing stomach cancer and about research aimed at the prevention of this disease.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: March 10, 2017

Coeliac Disease: Recognition, Assessment and Management

Coeliac disease is an autoimmune condition associated with chronic inflammation of the small intestine, which can lead to malabsorption of nutrients. Dietary proteins, known as glutens, which are present in wheat, barley and rye activate an abnormal mucosal immune response. Clinical and histological improvements usually follow when gluten is excluded from the diet.

NICE Guideline - Internal Clinical Guidelines Team (UK).

Version: September 2015
Show search results within this document

Stomach (Gastric) Cancer Prevention (PDQ®): Patient Version

Expert-reviewed information summary about factors that may influence the risk of developing stomach cancer and about research aimed at the prevention of this disease.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: December 1, 2015

Dyspepsia and Gastro-Oesophageal Reflux Disease: Investigation and Management of Dyspepsia, Symptoms Suggestive of Gastro-Oesophageal Reflux Disease, or Both

The guideline applies to adults (aged 18 and over) with symptoms suggestive of dyspepsia, symptoms suggestive of gastro-oesophageal reflux disease (GORD), or both.

NICE Clinical Guidelines - Internal Clinical Guidelines Team (UK).

Version: September 2014
Show search results within this document

Gastric Cancer Treatment (PDQ®): Health Professional Version

Expert-reviewed information summary about the treatment of gastric cancer.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: February 2, 2017

Gastrointestinal Carcinoid Tumors Treatment (PDQ®): Patient Version

Expert-reviewed information summary about the treatment of gastrointestinal carcinoid tumors.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: July 19, 2016

Gastrointestinal Carcinoid Tumors Treatment (PDQ®): Health Professional Version

Expert-reviewed information summary about the treatment of gastrointestinal carcinoid tumors.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: July 8, 2015

Diagnosis and Management of Infantile Hemangioma [Internet]

To systematically review evidence addressing the diagnosis and management of infantile hemangiomas (IH).

Comparative Effectiveness Reviews - Agency for Healthcare Research and Quality (US).

Version: January 2016
Show search results within this document

Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions?

BACKGROUND: Proton pump inhibitors (PPIs) are the most effective agents available for reducing acid secretion. They are used for medical treatment of various acid-related disorders. PPIs are used extensively and for extended periods of time in gastroesophageal reflux disease (GERD). A troublesome issue regarding maintenance therapy has been the propensity of PPI-treated patients to develop chronic atrophic gastritis while on therapy that could theoretically lead to an increased incidence of gastric cancer. In addition, animal studies have raised concern for development of enterochromaffin-like cell hyperplasia and carcinoid tumors in the stomachs of mice receiving high dose PPIs. Current literature does not provide a clear-cut conclusion on the subject and the reports are sometimes contradictory. Therefore, this study is a systematic review of the available literature to address the safety of long-term PPI use and its relation to the development of malignant/premalignant gastric lesions.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2013

Meta-analysis: folic acid in the chemoprevention of colorectal adenomas and colorectal cancer

This well-conducted review concluded that there was no evidence that folic acid was effective in the chemo-prevention of colorectal adenomas or colorectal cancer for any population. The authors' conclusions reflected the results and are likely to be reliable, but the authors also noted that there were concerns with the small number of trials and the short duration of follow-up.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2010

Systematic Reviews in PubMed

See all (58)...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...